REBEKAH EPPERLY: Open Payments
NPI 1174299879 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 38 payments from 12 companies in 2025. Trend: 2023 $737 · 2024 $700 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $447 |
| ABBVIE INC. | 3 | $68 |
| Lilly USA, LLC | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $18 |
Products named: Rybelsus, Ozempic, Wegovy, MOUNJARO, VOQUEZNA, Kerendia, SYNTHROID, SPRAVATO.
Industry payments across WV — which companies pay providers there.
